In the BioHarmony Drug Report Database

"Preview" Icon

Romiplostim

Nplate (romiplostim) is a protein pharmaceutical. Romiplostim was first approved as Nplate on 2008-08-22. It is used to treat thrombocytopenic purpura idiopathic in the USA. It has been approved in Europe to treat thrombocytopenic purpura idiopathic. The pharmaceutical is active against thrombopoietin receptor.

 

Trade Name

 

Nplate
 

Common Name

 

romiplostim
 

ChEMBL ID

 

CHEMBL1201832
 

Indication

 

thrombocytopenic purpura idiopathic
 

Drug Class

 

Colony-stimulating factors

Image (chem structure or protein)

Romiplostim structure rendering